ANTIBODY-MEDIATED REJECTION OF KIDNEY GRAFTS: COMPARISON OF STANDARD THERAPY AND THERAPY WITH ADDITION OF BORTEZOMIB AND/ OR RITUXIMAB

被引：0
|
作者：
Oblak, Teja [1 ]
Lindic, Jelka [1 ]
Kveder, Radoslav [1 ]
Rigler, Andreja Ales [1 ]
Skoberne, Andrej [1 ]
Haler, Zeljka Veceric [1 ]
Borstnar, Spela [1 ]
Avgustin, Nusa [1 ]
Gubensek, Jakob [1 ]
Ponikvar, Rafael [1 ]
Mlinsek, Gregor [1 ]
Ferluga, Dusan [2 ]
Kojc, Nika [2 ]
Kovac, Damjan [1 ]
机构：
[1] Univ Med Ctr Ljubljana, Dept Nephrol, Ljubljana, Slovenia
[2] Univ Ljubljana, Inst Pathol, Med Fac, Ljubljana, Slovenia
来源：
TRANSPLANT INTERNATIONAL | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
MP059
引用
收藏
页码：386 / 386
页数：1
相关论文
共 50 条
  • [1] ANTIBODY-MEDIATED REJECTION OF KIDNEY GRAFTS: COMPARISON OF STANDARD THERAPY AND THERAPY WITH ADDITION OF BORTEZOMIB AND/OR RITUXIMAB
    Oblak, Teja
    Lindic, Jelka
    Gubensek, Jakob
    Kveder, Radoslav
    Rigler, Andreja Ales
    Skoberne, Andrej
    Haler, Zeljka Veceric
    Borstnar, Spela
    Avgustin, Nusa
    Ponikvar, Rafael
    Mlinsek, Gregor
    Ferluga, Dusan
    Kojc, Nika
    Godnov, Uros
    Kovac, Damjan
    TRANSPLANT INTERNATIONAL, 2017, 30 : 554 - 554
  • [2] Treatment of antibody-mediated rejection of kidney grafts with bortezomib and/or rituximab compared to standard regimen: experience of Slovene National Center
    Oblak, Teja
    Lindic, Jelka
    Gubensek, Jakob
    Kveder, Radoslav
    Rigler, Andreja Ales
    Skoberne, Andrej
    Haler, Zeljka Veceric
    Borstnar, Spela
    Avgustin, Nusa
    Ponikvar, Rafael
    Mlinsek, Gregor
    Ferluga, Dusan
    Kojc, Nika
    Godnov, Uros
    Kovac, Damjan
    CLINICAL NEPHROLOGY, 2017, 88 : S91 - S96
  • [3] Comparison between bortezomib and rituximab in the treatment of antibody-mediated renal allograft rejection
    Waiser, Johannes
    Budde, Klemens
    Schuetz, Manuela
    Liefeldt, Lutz
    Rudolph, Birgit
    Schoenemann, Constanze
    Neumayer, Hans-H
    Lachmann, Nils
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (03) : 1246 - 1251
  • [4] Comparison of Bortezomib in Addition to Rituximab Based Treatment of Acute Antibody Mediated Rejection in Kidney Transplantation.
    Mattiazzi, A.
    Pagan, J.
    Arunachalam, A.
    Alcantara, I. De la Cruz
    Revollo, J.
    Centeno, A.
    Valdes, A.
    Guerra, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 510 - 510
  • [5] Treatment of Antibody-Mediated Renal Allograft Rejection with Bortezomib or Rituximab
    Waiser, Johannes
    Schuetz, Manuela
    Liefeldt, Lutz
    Schoenemann, Constanze
    Neumayer, Hans-H.
    Budde, Klemens
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 466 - 467
  • [6] Promising new therapy for antibody-mediated rejection in kidney transplants
    Khan, Usama
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2024, 56 (12) : 3933 - 3934
  • [7] The Effect of Bortezomib on Antibody-Mediated Rejection after Kidney Transplantation
    Lee, Juhan
    Kim, Beom Seok
    Park, Yongjung
    Lee, Jae Geun
    Lim, Beom Jin
    Jeong, Hyeon Joo
    Kim, Yu Seun
    Huh, Kyu Ha
    YONSEI MEDICAL JOURNAL, 2015, 56 (06) : 1638 - 1642
  • [8] Bortezomib rescue therapy in a patient with recurrent antibody-mediated rejection after lung transplantation
    Baum, Christina
    Reichenspurner, Hermann
    Deuse, Tobias
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (12): : 1270 - 1271
  • [9] COMBINATION THERAPY OF RITUXIMAB AND INTRAVENOUS IMMUNOGLOBULIN AS AN EFFECTIVE TREATMENT FOR CHRONIC ANTIBODY-MEDIATED REJECTION IN KIDNEY TRANSPLANT RECIPIENTS
    Park, Woo Yeong
    Kang, Seong Sik
    Jin, Kyubok
    Park, Sung Bae
    Han, Seungyeup
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [10] Bortezomib: A New Promising Therapy for Early Antibody-Mediated Rejection After Liver Transplantation?
    Chedid, Marcio F.
    Rodrigo, Emilio
    TRANSPLANTATION DIRECT, 2019, 5 (10):
12345